Microparticle content of plasma for transfusion is influenced by the whole blood hold conditions: Pre-analytical considerations for proteomic investigations

被引:16
|
作者
Sparrow, Rosemary L. [1 ]
Chan, Kasey Sze-Kei [1 ]
机构
[1] Australian Red Cross Blood Serv, Melbourne, Vic, Australia
关键词
Microparticles; Phosphatidylserine; Plasma; Platelets; Transfusion; Whole blood; FRESH-FROZEN PLASMA; FLOW-CYTOMETRIC ANALYSIS; ANTIOXIDANT CAPACITY; MASSIVE TRANSFUSION; PROTAGONISTS; COAGULOPATHY; CONCENTRATE; COLLECTION; VESICLES; EXOSOMES;
D O I
10.1016/j.jprot.2012.07.013
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Microparticles (MPs) are shed from normal blood cells and may contribute to the coagulation potential of plasma. Transfusion of fresh frozen plasma (FFP) is used to correct coagulopathies and blood loss in trauma or major surgery. The role of MPs in FFP clinical efficacy is unknown. Regulations that govern the preparation of FFP vary in different countries. The aim of this study was to determine the effect of whole blood (WB)-hold conditions before FFP preparation on the MP profile. WB units were held at room temperature (RT) or combination of RT and refrigeration for up to 24 h before FFP preparation. The MP content in thawed FFP was measured to reflect transfusion practice. The absolute number of MPs in FFP increased with longer WB hold time. Refrigeration of WB may also promote increased generation of MPs. In particular the number of platelet-derived and phosphatidylserine-containing MPs, which are known to have procoagulant properties, increased. Lipid peroxidation increased with longer WB-hold time. Donor-related factors appear to govern lipid peroxidation levels. Holistic proteomic and coagulant analyses of FFP MPs are warranted. Such information could guide the choice of the optimal handling conditions of WB and the most relevant quality control procedures for FFP. This article is part of a Special Issue entitled: Integrated omics. Crown Copyright (C) 2012 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:211 / 219
页数:9
相关论文
共 6 条
  • [1] Influence of pre-analytical conditions on the interpretation of zopiclone concentrations in whole blood
    Nilsson, Gunnel H.
    Kugelberg, Fredrik C.
    Ahlner, Johan
    Kronstrand, Robert
    FORENSIC SCIENCE INTERNATIONAL, 2011, 207 (1-3) : 35 - 39
  • [2] PRE-ANALYTICAL CONSIDERATIONS IN STUDYING CIRCULATING MICRORNA EXPRESSION: COMPARISON BETWEEN PAIRED EDTA PLASMA, EDTA WHOLE BLOOD AND PAXGENE BLOOD RNA TUBES
    Wijtvliet, Veerle
    Van Craenenbroeck, Amaryllis
    Smet, Annemieke
    Van Laere, Steven
    Massart, Annick
    De Winter, Benedicte
    Abramowicz, Daniel
    Ledeganck, Kristien
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1932 - 1932
  • [3] Pre-analytical stability of adrenocorticotrophic hormone from healthy horses in whole blood, plasma and frozen plasma samples
    Prutton, James S. W.
    Kass, Philip H.
    Watson, Johanna L.
    Pusterla, Nicola
    VETERINARY JOURNAL, 2015, 204 (01): : 123 - 124
  • [4] Liquid Biopsy Preservation Solutions for Standardized Pre-Analytical Workflows-Venous Whole Blood and Plasma
    Groelz, Daniel
    Hauch, Siegfried
    Schlumpberger, Martin
    Guenther, Kalle
    Voss, Thorsten
    Sprenger-Haussels, Markus
    Oelmueller, Uwe
    CURRENT PATHOBIOLOGY REPORTS, 2018, 6 (04) : 275 - 286
  • [5] Microparticle Profile and Procoagulant Activity of Fresh Frozen Plasma is Affected by the Whole Blood-Hold Conditions and Leukocyte Depletion Prior to Processing
    Chan, K. S.
    Sparrow, R. L.
    TRANSFUSION, 2012, 52 : 54A - 55A
  • [6] From Bed to Bench: Pre-analytical Stability of 29 Anti-infective Agents in Plasma and Whole Blood to Improve Accuracy of Therapeutic Drug Monitoring
    Magreault, Sophie
    Pierredon, Dorine
    Akinotcho-Relouzat, Judith
    Mechai, Frederic
    Lamy, Brigitte
    Jaureguy, Francoise
    Jullien, Vincent
    THERAPEUTIC DRUG MONITORING, 2024, 46 (06) : 725 - 734